Causes and Severity of Ischemic Stroke in Patients With Symptomatic Intracranial Arterial Stenosis

Background and Purpose— There are limited data on the causes and severity of subsequent stroke in patients presenting initially with TIA or stroke attributed to intracranial arterial stenosis. Methods— We evaluated the location, type (lacunar vs nonlacunar), cause, and severity of stroke in patients who had an ischemic stroke endpoint in the Warfarin Aspirin Symptomatic Intracranial Disease (WASID) trial. Results— Of the 569 patients enrolled in the WASID trial, 106 patients (18.6%) had an ischemic stroke during a mean follow-up of 1.8 years. Stroke occurred in the territory of the symptomatic artery in 77 (73%) of 106 patients. Among the 77 strokes in the territory, 70 (91%) were nonlacunar and 34 (44%) were disabling. Stroke out of the territory of the symptomatic artery occurred in 29 (27%) of 106 patients. Among these 29 strokes, 24 (83%) were nonlacunar, 14 (48%) were attributed to previously asymptomatic intracranial stenosis, and 9 (31%) were disabling. Conclusions— Most subsequent strokes in patients with symptomatic intracranial artery stenosis are in the same territory and nonlacunar, and nearly half of the strokes in the territory are disabling. The most commonly identified cause of stroke out of the territory was a previously asymptomatic intracranial stenosis. Penetrating artery disease was responsible for a low number of strokes.

[1]  M. Daffertshofer,et al.  Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease , 2005, Neurology.

[2]  M. Eliasziw,et al.  Causes and severity of ischemic stroke in patients with internal carotid artery stenosis. , 2000, JAMA.

[3]  H. Katayama,et al.  Contrast sonography for detection of vesicoureteral reflux , 1994, The Lancet.

[4]  S. Kasner,et al.  Risk factor status and vascular events in patients with symptomatic intracranial stenosis , 2007, Neurology.

[5]  W. J. Hamilton,et al.  Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial , 1996, The Lancet.

[6]  H. A. Smith,et al.  A standardized method for measuring intracranial arterial stenosis. , 2000, AJNR. American journal of neuroradiology.

[7]  Stroke Investigators.  Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study , 1994, The Lancet.

[8]  H. White,et al.  Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation : stroke prevention in atrial fibrillation II study. Commentary , 1994 .

[9]  Olaf Gefeller,et al.  Epidemiology of Ischemic Stroke Subtypes According to TOAST Criteria: Incidence, Recurrence, and Long-Term Survival in Ischemic Stroke Subtypes: A Population-Based Study , 2001, Stroke.

[10]  B. Norrving.  Long-term prognosis after lacunar infarction , 2003, The Lancet Neurology.

[11]  H. Chugani,et al.  An almost missed leptomeningeal angioma in Sturge-Weber syndrome , 2007, Neurology.

[12]  G. Landi,et al.  Lacunar versus non-lacunar infarcts: pathogenetic and prognostic differences. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[13]  S. Kasner,et al.  Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. , 2005, The New England journal of medicine.

[14]  M. B. Brown,et al.  The Warfarin-Aspirin Symptomatic Intracranial Disease Study , 1995, Neurology.

[15]  W M O'Fallon,et al.  Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. , 2000, Stroke.

[16]  P. Rothwell,et al.  Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies , 2004, Neurology.

[17]  J. Kirkpatrick,et al.  Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. , 1998, Journal of insurance medicine.

[18]  S. Kasner,et al.  Prevalence and Prognosis of Coexistent Asymptomatic Intracranial Stenosis , 2008, Stroke.

[19]  J. Saver,et al.  Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis , 2006, Neurology.

[20]  D. Sackett,et al.  Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. , 1998, The New England journal of medicine.

[21]  E Vicaut,et al.  Prospective study of symptomatic atherothrombotic intracranial stenoses , 2006, Neurology.

[22]  O. Bang,et al.  Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study. , 2005, Archives of neurology.

[23]  Harry J. Cloft,et al.  Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis , 2003, Neuroepidemiology.

[24]  C. Derdeyn,et al.  Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. , 2007, Neuroimaging clinics of North America.

[25]  Lippincott Williams Wilkins,et al.  Stroke Prevention in Atrial Fibrillation Study: Final Results , 1991, Circulation.

[26]  J. Bogousslavsky,et al.  Mechanisms of second and further strokes , 1997, Journal of neurology, neurosurgery, and psychiatry.